Moderna’s Stock Fell After Early Data Showed Its MRNA-based Flu Vaccine Was No Better ... - Latest Tweet by Reuters

Moderna’s stock fell after early data showed its mRNA-based flu vaccine was no better than flu shots already approved. The selloff prompted a plea from company executives for investors to wait for more data https://t.co/7xVMDoLn96 pic.twitter.com/euPj51bg7N— Reuters (@Reuters) December 11, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)